Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
(←Replaced content with '{{Navbox | name = Lipid modifying agents | title = Lipid modifying agents (C10) | groupstyle = backg }}') |
imported>ClueBot m (Reverting possible vandalism by 140.142.221.254 to version by Rudolf Virchow. False positive? Report it. Thanks, ClueBot. (590709) (Bot)) |
||
| Line 2: | Line 2: | ||
| name = Lipid modifying agents | | name = Lipid modifying agents | ||
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | | title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | ||
| − | | groupstyle = | + | | groupstyle = background:MistyRose; |
| + | |||
| + | | group1 = [[GI tract]] | ||
| + | | list1 = {{Navbox subgroup | ||
| + | | groupstyle = background:MistyRose; | ||
| + | |||
| + | | group1 = [[Cholesterol absorption inhibitor]], [[NPC1L1]] | ||
| + | | list1 = [[Ezetimibe]]{{•}} [[Sch-48461]] | ||
| + | |||
| + | | group2 = [[Bile acid sequestrant|Bile acid sequestrants]]/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]]) | ||
| + | | list2 = [[Cholestyramine|Cholestyramine]]{{•}} [[Colestipol]]{{•}} [[Colestilan]]{{•}} [[Colextran]]{{•}} [[Colesevelam]] | ||
| + | |||
}} | }} | ||
| + | |||
| + | |||
| + | | group2 = [[Liver]] | ||
| + | | list2 = {{Navbox subgroup | ||
| + | | groupstyle = background:MistyRose; | ||
| + | |||
| + | | group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]]) | ||
| + | | list1 = [[Atorvastatin]]{{•}} [[Cerivastatin]]<sup>‡</sup>{{•}} [[Fluvastatin]]{{•}} [[Lovastatin]]{{•}} [[Mevastatin]]{{•}} [[Pitavastatin]]{{•}} [[Pravastatin]]{{•}} [[Rosuvastatin]]{{•}} [[Simvastatin]] # | ||
| + | |||
| + | | group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]]) | ||
| + | | list2 = [[Niceritrol]]{{•}} [[Niacin]]{{•}} [[Nicofuranose]]{{•}} [[Aluminium nicotinate]]{{•}} [[Nicotinyl alcohol]]{{•}} [[Acipimox]] | ||
| + | |||
| + | }} | ||
| + | |||
| + | | group4 = [[Blood vessel]]s | ||
| + | | list4 = {{Navbox subgroup | ||
| + | | groupstyle = background:MistyRose; | ||
| + | |||
| + | | group1 = [[Fibrate]]s ([[PPAR modulator|PPAR]]) | ||
| + | | list1 = [[Clofibrate]]<sup>‡</sup>{{•}} [[Bezafibrate]]{{•}} [[Aluminium clofibrate]]{{•}} [[Gemfibrozil]]{{•}} [[Fenofibrate]]{{•}} [[Simfibrate]]{{•}} [[Ronifibrate]]{{•}} [[Ciprofibrate]]{{•}} [[Etofibrate]]{{•}} [[Clofibride]]{{•}} [[Clinofibrate]] | ||
| + | |||
| + | |||
| + | | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]]) | ||
| + | | list2 = [[Anacetrapib]]<sup>†</sup>{{•}} [[Torcetrapib]]<sup>§</sup>{{•}} [[JTT-705]] | ||
| + | |||
| + | |||
| + | |||
| + | }} | ||
| + | |||
| + | |||
| + | | group7 = Combinations | ||
| + | | list7 = [[Niacin/lovastatin]]{{•}} [[Niacin/simvastatin]]{{•}} [[Ezetimibe/simvastatin]] | ||
| + | |||
| + | | group8 = Other | ||
| + | | list8 = [[Dextrothyroxine]]{{•}} [[Probucol]]{{•}} [[Tiadenol]]{{•}} [[Benfluorex]]{{•}} [[Meglutol]]{{•}} [[Omega-3-triglycerides]]{{•}} [[Magnesium pyridoxal 5-phosphate glutamate]]{{•}} [[Policosanol]]{{•}} [[Lapaquistat]]<sup>§</sup>{{•}} [[Alipogene tiparvovec]] | ||
| + | |||
| + | | list9 = <sup>†</sup>Undergoing [[clinical trial]]s. <sup>‡</sup>[[List of withdrawn drugs|Withdrawn]] from market. <sup>§</sup>[[Drug development|Development]] terminated. # = [[List of World Health Organization Essential Medicines|WHO-EM]] | ||
| + | }}<noinclude> | ||
| + | |||
| + | [[Category:Drug templates|{{PAGENAME}}]] | ||
| + | </noinclude> | ||